Weaver C. Barksdale & Associates’s Medical Properties Trust MPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$4K Buy
263
+24
+10% +$324 ﹤0.01% 398
2017
Q3
$3K Buy
239
+10
+4% +$129 ﹤0.01% 424
2017
Q2
$3K Buy
229
+5
+2% +$67 ﹤0.01% 439
2017
Q1
$3K Sell
224
-19
-8% -$243 ﹤0.01% 449
2016
Q4
$3K Buy
243
+75
+45% +$971 ﹤0.01% 445
2016
Q3
$2K Buy
168
+15
+10% +$227 ﹤0.01% 475
2016
Q2
$2K Buy
+153
New +$2.17K ﹤0.01% 467

Other funds holding MPT

Weaver C. Barksdale & Associates's MPT Position: Q4 2017 in Review

Weaver C. Barksdale & Associates increased its Medical Properties Trust (MPT) stake by 10% in Q4 2017, buying an estimated $324 and bringing the position to 263 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #398.

Weaver C. Barksdale & Associates first reported a position in MPT in Q2 2016 and has held it in 7 quarters since. 361 funds tracked by Wall St. Rank hold MPT as of Q4 2017.

  • Weaver C. Barksdale & Associates held 263 shares of Medical Properties Trust worth $4K as of Q4 2017.
  • Weaver C. Barksdale & Associates bought 24 Medical Properties Trust shares in Q4 2017, an estimated $324.
  • Medical Properties Trust made up ﹤0.01% of Weaver C. Barksdale & Associates's portfolio in Q4 2017, its #398 holding.
  • Weaver C. Barksdale & Associates first reported a position in Medical Properties Trust in Q2 2016 and has held it in 7 quarters since.
  • 361 funds tracked by Wall St. Rank held Medical Properties Trust as of Q4 2017.

Based on Weaver C. Barksdale & Associates's 13F filing for Q4 2017, filed 10 Jan 2018.